JP2024546600A5 - - Google Patents
Info
- Publication number
- JP2024546600A5 JP2024546600A5 JP2024530446A JP2024530446A JP2024546600A5 JP 2024546600 A5 JP2024546600 A5 JP 2024546600A5 JP 2024530446 A JP2024530446 A JP 2024530446A JP 2024530446 A JP2024530446 A JP 2024530446A JP 2024546600 A5 JP2024546600 A5 JP 2024546600A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- alkyl
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290783P | 2021-12-17 | 2021-12-17 | |
| US63/290,783 | 2021-12-17 | ||
| US202263312696P | 2022-02-22 | 2022-02-22 | |
| US63/312,696 | 2022-02-22 | ||
| PCT/US2022/053113 WO2023114456A1 (en) | 2021-12-17 | 2022-12-16 | Uses of bicyclic compounds for the treatment of diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546600A JP2024546600A (ja) | 2024-12-26 |
| JP2024546600A5 true JP2024546600A5 (https=) | 2025-12-23 |
Family
ID=86773494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024530446A Pending JP2024546600A (ja) | 2021-12-17 | 2022-12-16 | 疾患の治療のための二環式化合物の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250041307A1 (https=) |
| EP (1) | EP4448100A4 (https=) |
| JP (1) | JP2024546600A (https=) |
| KR (1) | KR20240121239A (https=) |
| AU (1) | AU2022410646A1 (https=) |
| CA (1) | CA3240896A1 (https=) |
| CL (1) | CL2024001748A1 (https=) |
| IL (1) | IL313039A (https=) |
| MX (1) | MX2024005884A (https=) |
| TW (1) | TW202339756A (https=) |
| WO (1) | WO2023114456A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025515045A (ja) * | 2022-05-04 | 2025-05-13 | アティラ・ファーマ・インコーポレイテッド | 神経炎症病態を治療する方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184223B1 (en) * | 1995-10-27 | 2001-02-06 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
| AU2003284120A1 (en) * | 2002-10-17 | 2004-05-04 | Myriad Genetics, Inc. | Reverse-turn mimetics and composition and methods relating thereto |
| EP2155226A4 (en) * | 2007-06-14 | 2010-07-28 | Univ California | COMPOUNDS FOR INHIBITING THE PROTEIN AGGREGATION AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| KR20130139895A (ko) * | 2010-09-02 | 2013-12-23 | 다케다 야쿠힌 고교 가부시키가이샤 | 경도인지 장애의 치료 또는 예방용 융합 트리아졸 |
| CA2817975C (en) * | 2010-11-16 | 2020-03-31 | Michael Kahn | Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| AP2014007606A0 (en) * | 2011-10-07 | 2014-05-31 | Takeda Pharmaceutical | 1-Arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| CN119684295A (zh) * | 2020-11-02 | 2025-03-25 | 雅斯娜制药公司 | 用于治疗疾病的双环化合物及其用途 |
-
2022
- 2022-12-16 KR KR1020247019794A patent/KR20240121239A/ko active Pending
- 2022-12-16 IL IL313039A patent/IL313039A/en unknown
- 2022-12-16 US US18/716,404 patent/US20250041307A1/en active Pending
- 2022-12-16 EP EP22908476.9A patent/EP4448100A4/en active Pending
- 2022-12-16 CA CA3240896A patent/CA3240896A1/en active Pending
- 2022-12-16 WO PCT/US2022/053113 patent/WO2023114456A1/en not_active Ceased
- 2022-12-16 JP JP2024530446A patent/JP2024546600A/ja active Pending
- 2022-12-16 MX MX2024005884A patent/MX2024005884A/es unknown
- 2022-12-16 TW TW111148490A patent/TW202339756A/zh unknown
- 2022-12-16 AU AU2022410646A patent/AU2022410646A1/en active Pending
-
2024
- 2024-06-13 CL CL2024001748A patent/CL2024001748A1/es unknown